DUBLIN, March 3, 2023 /PRNewswire/ -- The "Allergy Diagnostics: Global Strategic Business Report" report has been added to
Global Allergy Diagnostics Market to Reach $8.3 Billion by 2030
The global market for Allergy Diagnostics estimated at US$3.8 Billion in the year 2022, is projected to reach a revised size of US$8.3 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2022-2030.
Assay Kits, one of the segments analyzed in the report, is projected to record a 11% CAGR and reach US$4.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 10.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 15% CAGR
The Allergy Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 15% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.7% and 9.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2030.
What`s New for 2023?
Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year
Key Topics Covered:
MARKET TRENDS & DRIVERS
Development of Effective Allergy Diagnostic Products Cuts Down on Healthcare Spending
Labs Embrace Automation and Advanced Allergy Tests for Fast Turnaround Times
Food Allergies - A Major and Growing Concern
Select Digital Technologies to Provide Help in Managing Food Allergy
Food Allergies Create Opportunities for Food Allergy Testing
ELISA Gains Lead as Preferred Food Testing Method
Need to Offer Quality Services at Affordable Costs Prompts Labs to Consider Reagent Rental Agreements
In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing Market
Macro Array Diagnostics Unveils Allergy Explorer for Allergy Diagnostics
Rising Alcohol and Drug Abuse Increases Demand for Allergy Diagnostics
Increasing Cases of Allergies Drive Development of Advanced Allergy Diagnostics Solutions
Focus on Single and Protein Allergens
IgE Antibody Tests
Allergy Diagnostic Reagents on Microchip
Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
Patch Test to Experience Healthy Growth
SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch Test for Pediatric Use
Providers of Allergy Diagnostic Services Focus on Vertical Integration
Allergic Diagnostic Challenges in Patients
Enhanced Access to Allergy Diagnosis Medical Insurance & Instrument Allowances in the US Widen Market Prospects
Typical Cost Structure for Allergy Testing
Technological Advancements - Mobile Health Tools for Allergy Patients
Technological Advancements - Nanotechnology for Allergy Diagnostics
Application of Nanostructures for In-Vitro Diagnosis of Allergy
Application of Nanostructures in Drug-sIgE Detection
Application of Nanostructures for Detection of Allergen-sIgE
Select Recent Launches in the Allergy Diagnostics Market to Bolster Market Expansion
EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1 Test for Pollen Allergies
Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy Testing System
ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin Testing
CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for Accurate, Reliable Results
Increasing Prevalence and Incidence of Allergic Disorders to Drive the Demand for Allergy Diagnostics
Atopic Dermatitis (Eczema) Prevalence Rates among Global Adult Population
Environmental Changes and Pollution Aggravate Incidence of Allergic Reactions, Resulting in Increased Need for Allergy Diagnostics
Major Environmental Factors with Link to Allergic Diseases
Growing Number of Food Allergy Cases Fuels Demand for Allergy Testing Kits
Prevalence Rate of Five Common Food Allergies among US Adults
Factors Responsible for Rising Prevalence of Food Allergy
Burgeoning Aging Population and Longer Life Expectancy to Drive Allergy Diagnostics Market
Inadequate Knowledge about Food Allergy Inhibits Growth of Allergy Diagnostic Market
Expensive Nature of Allergy Diagnostics Approaches Limits Market Growth
New Regulations and Statutory Provisions to Affect Diagnostic Allergen Extracts
Allergens: A Prelude
Key Allergy Stats
Allergy: Symptoms and Causes
Allergic Diagnostics: An Introduction
Food Allergen Testing
Impact of Covid-19 and a Looming Global Recession
The Never-Ending "Race" Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
Time is of Essence! What We Know So Far - "Vaccine Efficiency Against New Strains"
With New Strains Emerging at an Alarming Rate, Focus Shifts to Booster Doses & Vaccine Tweaking. But How Practical Is It to Implement Them?
With Vaccinated Population Showing Signs of Declining Clinical Protection, Booster Doses Are Emerging Into a Necessity to Restore Vaccine Effectiveness
A Strong Yet Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Allergy Diagnostics Market Under the Covid Lens
Telemedicine Gains Prominence amid the Pandemic
Global Allergy Diagnostics Market Set to Witness Rapid Growth
With Allergies on the Rise for Whatever Reason Be It Our Neanderthal Genes or Hygiene Hypothesis or Vitamin D Hypothesis, the Need for Effective Diagnostics Has Never Been Greater
Global Prevalence of Allergies (In Million)
Assay Kits Dominate the Allergy Diagnostics Market
Inhaled Allergens Segment to Witness Fastest Growth
US Dominates the Allergy Diagnostics Market, While China to Witness the Fastest Growth
Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2021 (E)
FOCUS ON SELECT PLAYERS
(Total 100 Featured)
Allergy Therapeutics PLC
Angsana Molecular & Diagnostics Laboratory Pte. Ltd.
Astra Biotech GmbH
Demeditec Diagnostics GmbH
EUROIMMUN Medizinische Labordiagnostika AG
GA Generic Assays GmbH
INDOOR Biotechnologies, Inc.
Lincoln Diagnostics, Inc.
Omega Diagnostics Group Plc
Roxall Medizin GmbH
Tecan Trading AG
Thermo Fisher Scientific Inc.
For more information about this report visit
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets